ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,871Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 300

$1.65M Total Retail Price of All Prescriptions

Rank: 3 out of 300

437 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

38% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

5% of this provider’s 17,182 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,188 756 S3 1 1
AMLODIPINE BESYLATE 871 716 2 2
LEVOCETIRIZINE DIHYDROCHLORIDE 727 541 10 3 81
NEXIUM 704 492 4 17
ATORVASTATIN CALCIUM 530 402 5 14
METFORMIN HCL 521 379 6 19
FLUTICASONE PROPIONATE 459 365 7 34
ALLOPURINOL 403 278 8 44
POTASSIUM CHLORIDE 393 303 9 22
WARFARIN SODIUM 383 291 10 10
FUROSEMIDE 357 303 11 3
DIOVAN 350 263 12 46
CLONIDINE HCL 326 239 13 50
MELOXICAM 306 251 14 27
CARISOPRODOL 305 98 R 15 36
SIMVASTATIN 295 226 16 5
CARVEDILOL 295 243 16 12
OMEPRAZOLE 293 229 18 11
GLIMEPIRIDE 283 212 19 51
QUINAPRIL HCL 258 157 20 128
LEVOTHYROXINE SODIUM 249 166 21 9
GABAPENTIN 243 133 22 7
ENALAPRIL MALEATE 215 160 23 86
LIPITOR 209 146 24 115
TRAMADOL HCL 195 151 25 23
JANUVIA 194 159 26 100
DEXILANT 191 135 27 119
PREMARIN 187 136 R 28 87
LISINOPRIL 185 130 29 4
BENICAR 182 140 30 191
CRESTOR 181 111 31 26
CYMBALTA 172 91 32 37
CLOPIDOGREL 169 116 33 18
ZOLPIDEM TARTRATE 168 117 34 21
PREDNISONE 167 122 35 33
METOPROLOL SUCCINATE 165 103 36 6
PRAVASTATIN SODIUM 163 109 37 15
SYNTHROID 155 131 38 49
TRILIPIX 153 106 39 253
ESCITALOPRAM OXALATE 149 104 40 78
CITALOPRAM HBR 148 132 41 54
AMITRIPTYLINE HCL 147 123 R 42 66
FENTANYL 145 48 S2 43 95
ACTOS 141 120 44 214
PANTOPRAZOLE SODIUM 141 95 44 35
COUMADIN 137 104 46 234
PLAVIX 133 96 47 24
LYRICA 132 109 48 55
ROPINIROLE HCL 130 118 49 121
DONEPEZIL HCL 130 130 49 57
CELEBREX 129 115 51 150
AMLODIPINE BESYLATE-BENAZEPRIL 128 121 52 52
NIFEDIPINE ER 126 102 53 120
DIGOXIN 120 114 54 39
METFORMIN HCL ER 119 89 55 131
NASONEX 118 84 56 158
CIPROFLOXACIN HCL 114 95 57 28
TAMSULOSIN HCL 114 76 57 8
NAMENDA 113 102 59 48
ATENOLOL 113 78 59 31
HYDROCHLOROTHIAZIDE 113 67 59 20
FLUOXETINE HCL 109 78 62 117
PROMETHAZINE HCL 109 48 R 62 103
LANTUS 107 73 64 125
SPIRIVA 105 80 65 84
HYDRALAZINE HCL 104 80 66 56
MEGESTROL ACETATE 104 70 R 66 273
CEFDINIR 101 78 68 272
RAMIPRIL 100 93 69 63
METOPROLOL TARTRATE 100 70 69 13
ISOSORBIDE MONONITRATE ER 100 85 69 32
ALPRAZOLAM 100 88 69 88
DOXYCYCLINE HYCLATE 99 70 73 83
CYCLOBENZAPRINE HCL 99 75 R 73 71
CEFADROXIL 92 71 75 312
SERTRALINE HCL 92 66 75 41
SINGULAIR 91 64 77 114
EXFORGE 89 54 78 175
RANITIDINE HCL 86 64 79 112
ZETIA 85 48 80 109
QUETIAPINE FUMARATE 84 62 81 79
LOSARTAN POTASSIUM 83 75 82 29
LEXAPRO 82 43 83 300
BUPROPION XL 82 39 83 171
GEMFIBROZIL 75 50 85 186
CARAFATE 74 61 86 306
OXYCODONE HCL-ACETAMINOPHEN 74 31 S2 86 62
VOLTAREN 72 60 88 232
DIOVAN HCT 71 37 89 94
AZELASTINE HCL 70 34 90 255
AZITHROMYCIN 69 57 91 72
ONGLYZA 69 48 91 231
ESTRADIOL 66 55 R 93 69
ACTONEL 66 48 93 266
TRAZODONE HCL 65 52 95 65
EXELON 63 53 96 123
LUNESTA 61 26 97 239
ADVAIR DISKUS 60 48 98 60
INSULIN SYRINGE 60 34 98 156
PIOGLITAZONE HCL 60 46 R 98 411
METOCLOPRAMIDE HCL 59 35 101 139
ABILIFY 58 17 102 132
MONTELUKAST SODIUM 58 40 102 198
PRAMIPEXOLE DIHYDROCHLORIDE 58 50 102 130
MECLIZINE HCL 55 54 105 147
METHYLPREDNISOLONE 55 43 105 179
COMBIVENT 55 42 105 218
POLYETHYLENE GLYCOL 3350 54 50 108 47
LOVASTATIN 54 44 108 68
LEVOXYL 53 52 110 260
SUCRALFATE 53 33 110 210
BENAZEPRIL HCL 52 42 112 73
BUMETANIDE 52 47 112 126
AMPHETAMINE SALT COMBO 52 0 S2 112 254
CLOBETASOL PROPIONATE 51 36 115 251
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.